WO1996001598A1 - Prosthetic devices - Google Patents

Prosthetic devices Download PDF

Info

Publication number
WO1996001598A1
WO1996001598A1 PCT/GB1995/001550 GB9501550W WO9601598A1 WO 1996001598 A1 WO1996001598 A1 WO 1996001598A1 GB 9501550 W GB9501550 W GB 9501550W WO 9601598 A1 WO9601598 A1 WO 9601598A1
Authority
WO
WIPO (PCT)
Prior art keywords
prosthesis
reinforcing structure
resiliently deformable
deformable material
cover
Prior art date
Application number
PCT/GB1995/001550
Other languages
French (fr)
Inventor
James Joseph Cassidy
William Pigg
Original Assignee
Smith & Nephew Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith & Nephew Plc filed Critical Smith & Nephew Plc
Priority to AU28020/95A priority Critical patent/AU2802095A/en
Publication of WO1996001598A1 publication Critical patent/WO1996001598A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2/441Joints for the spine, e.g. vertebrae, spinal discs made of inflatable pockets or chambers filled with fluid, e.g. with hydrogel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2/30965Reinforcing the prosthesis by embedding particles or fibres during moulding or dipping
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2/442Intervertebral or spinal discs, e.g. resilient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2/442Intervertebral or spinal discs, e.g. resilient
    • A61F2002/444Intervertebral or spinal discs, e.g. resilient for replacing the nucleus pulposus

Definitions

  • the present invention relates to prosthetic devices and in particular to such devices which deform when in use (e.g. when under compressive load).
  • One type of prosthesis is disclosed in US Patent No. 5047055 and comprises a hydrogel material in a shape which generally conforms to the intervertebral disc nucleus pulposes. When hydrated the hydrogel comprises a certain amount of free water which can leave the prosthesis when the disc is partially dehydrated or under mechanical pressure.
  • intervertebral disc nucleus prosthesis comprises a multiplicity of hydrogel beads.
  • the beads are covered by an external, semi-permeable membrane, which functions to retain the beads, but which permits fluids to flow in and out of the prosthetic nucleus.
  • hydrogel materials employed in these prior devices have a tendency to become weaker and less able to withstand compressive loading as they become more fully hydrated. This may lead to failure of the prosthesis by fragmentation of the prosthesis material.
  • the present invention seeks to reduce the risk of stress failure of said prostheses to reduce the risk of fragmentation which may lead to adverse reactions in a host.
  • a prosthesis comprising a composite of a synthetic resiliently deformable material having at least partially embedded therein a physically discrete reinforcing structure.
  • a further advantage of the prosthesis of the present invention is that it allows a wider range of resiliently deformable materials to be utilised than was hitherto the case. This is because the reinforcing structure can substantially contribute to the physical strength of the device, thereby allowing weaker deformable materials to be used than is the case with non reinforced prostheses.
  • the prosthesis of the present invention is suitable for replacing body components which are subject to repeated and variable compressive loads and may be shaped so as to correspond to suitable body components.
  • it may be used to replace the nucleus pulposus of the intervertebral disc, the intervertebral disc in its entirety, as a replacement for the articular cartilage in joints, in place of orthopaedic bearing surfaces (eg to replace polyethylene bearing surfaces), in total joint replacement implants such as the hip, knee, shoulder, wrist, ankle, fingers and toes, as a spacer to replace segments of bone or the bone in its entirety, as a space filling implant replacing soft tissue for orthopaedic, maxillo-facial, or plastic or reconstructive surgical applications - such as to replace or augment deficiencies in bone, cartilage or soft tissue.
  • the prosthesis is adapted to replace part or all of an intervertebral disc of a mammal, e.g. a human, and is shaped accordingly.
  • the prosthesis is adapted to replace an intervertebral disc nucleus and it therefore desirably has a shape generally corresponding to that of a natural disc nucleus.
  • it may comprise a plurality of sections which are adapted, when fitted together to approximate the shape of the natural disc nucleus.
  • the nucleus may be in two halves to allow easy manipulation and to facilitate minimally invasive surgical techniques.
  • the reinforcing structure can be located partially or totally within the resiliently deformable material and is formed of a material which is physically discrete from said resiliently deformable material (although the reinforcing structure may itself be resiliently deformable). It is thus distinguished from systems in which polymers forming the resiliently deformable material are simply cross-linked.
  • the material comprising the reinforcing structure may also be chemically distinct from that of the resilient material.
  • the reinforcing structure may function by providing a restraining means within the deformable material which reduces the tendency of the latter to shear or otherwise fail when under compressive load.
  • the resiliently deformable material is in solid or semi-solid form. It may be an elastomeric polymer. Preferably it is hydrogel or a hydrophilic polymer.
  • Suitable hydrogels include PVA hydrogels, such as those disclosed in US-A-5192326.
  • hydrogels or hydrophilic polymers include:
  • Acrylates - eg acrylic acid, methacrylic acid, 2-hydroxyethyl methacrylate, and copolymers thereof with N-vinyl pyrrolidone, N- vinyl lactams, acylamide, polyurethanes, polyacrylonitrile; copolymers of N-vinyl pyrrolidone and glycidyl acrylate, copolymers of polyethylene, polytetrafluoroethylene or polypropylene with acrylic acid, block copolymers of poly (2-hydroxyethyl methacrylate) with polystyrene, or poly (dimethyl-siloxane), para-hydroxyperfluoro-alkyl styrene, or trifluoroethyl methacrylate;
  • Acrylamides eg acrylamide, methacrylamide and copolymers of acrylamides such as poiyacrylamide-agarose gels, siloxy-acryiamides;
  • Silicones - eg 1 ,3-bis-methacryloxy-propyl-1 ,1 ,3,3-tetrakis (trimethyl-siloxy) disiloxane, tris (trimethyl-siloxy) silyl-propyl methacrylate, siioxane monomers, polysiloxane-polyoxyalkylene macromers, silicone rubbers, hexamethyl disiloxane, triethoxyvinyl silane, hexamethyl disilazane;
  • Collagen - eg copolymers with poly (2-hydroxyethyl-acrylate) or poly (vinyl alcohol);
  • Vinyl compounds - eg N-vinyl pyrrolidone, N-vinyl lactams, hydroxyethyl cellulose vinyl and vinylic monomer, polymers of vinyl carbonate or vinyl carbamate, vinyl trifluro acetate;
  • Polyurethanes - eg polyether, or short chain polyester based polyurethanes.
  • Naturally occurring materials eg glucomannan gel, hyaluronic acid, proteins, poiysaccharides or polypeptides combined with a polymer of a hydrophilic acrylic or methacryiic acid derivative, crosslinked carboxyl containing polysaccharides, carboxymethyl cellulose, gelatin, aiginates.
  • Preferred hydrogels have a water content of at least 30%
  • elastomeric polymers which may be suitable for use in the present invention include:- silicone and fluorosilicone elastomers, phosphazene elastomers, vinylidine fluoride based fluoroelastomers, natural and artificial rubbers, etc.
  • the prosthesis of the invention aptly has a compressive strength of at least 1 MNrrr 2 at 37°C and at atmospheric pressure.
  • Suitable reinforcing structures include:- nets; foams; knitted, braided, crocheted, woven, or non-woven fabrics; arrays of spaced reinforcing elements; particulate filler materials; loose fibres.
  • net includes perforate films as well as fibrous networks. Suitable nets include those formed of nylonTM, dacronTM, carbon fibre etc.
  • the foams may be open cell foams, closed cell foams, skeletal foams, non-skeletal foams, etc.
  • Foams which are already used in wound-dressings for example those polyurethane foams employed in wound dressings such as ALLEVYNTM foam, which is sold by Smith & Nephew Medical Ltd, Hull, UK may be particularly suitable.
  • the fabrics used for reinforcing structures are aptly arranged as composite structures having desirably first and second spaced apart sheets whose opposed surfaces are maintained in a spaced apart relationship by a plurality of supporting members.
  • the first and second spaced apart surfaces may be generally parallel to one another (when the fabric is not compressed). They may be generally planar or may present corrugated surfaces.
  • Such fabrics are often formed by warp knitting using Raschel warp knitting machinery (as described eg in USPN 4601940 and EP-A-0529671). Certain type of fabrics of this are sometimes referred to as "spacer fabric” and have been used in seating in the automotive industry. Such fabrics can be obtained from Messrs. Nippon Mayer Co. Ltd. of J-910 Fukui City, Japan; M ⁇ ller Textile GmbH of D-51674 Wiehl- Drabenderh ⁇ he, Germany; or Karl Mayer Textilmaschienen fabrik of D-63160 Obertsha ⁇ sen, Germany.
  • the surfaces of these composite structures may be maintained in the spaced apart relationship by, for example, columns of elastomeric material or by a plurality of fibrous members arranged, for example to form a web.
  • Such webs may be formed from non-woven fabrics.
  • the particulate filler material may employed is the reinforcing structure may be quartz, silica, gypsum, titanium dioxide, glass based fillers, clay-based fillers, or calcium carbonate. Filler materials are described in detail in the "Handbook of Fillers for Plastics" by Katz and Mikwski [1987], published by Van Nostrand Reinhold.
  • the resiliently deformable material may be contained within an outer cover, which is desirably flexible.
  • the outer cover is suitably non-permeable to body fluids.
  • the outer cover may be provided to simply serve to assist in maintaining integrity or strength of the prosthesis.
  • the outer cover may therefore be permeable to body fluids but prevent the resiliently deformable material and the reinforcing structure from passing through it.
  • Aptly such outer covers will be in the form of a membrane or mesh.
  • Various outer covers are disclosed in US-A- 5192326.
  • This may take the form of a collar surrounding the prosthesis to constrain its lateral deflection.
  • This collar may be of metal, polymeric, ceramic or composite construction and would surround the prosthesis circumferentially.
  • This collar may be made of implantable metals such as stainless steel, cobalt chrome alloy, titanium alloy or ceramic materials such as alumina or zirconia, or composite materials such as carbon fibre reinforced PEEK, or polymers such as polyethylene.
  • the prosthesis may be bonded to plates of metal, ceramic, polymer or composite construction which are interspersed between the prosthesis and the bone of the vertebral bodies in cephalad and caudad directions to facilitate anchorage to the bone.
  • the prosthesis of the present invention is necessary to introduce it into a host. This can be done by any appropriate surgical technique, but minimally invasive techniques are preferred where possible.
  • a prosthesis consisting of an inter ⁇ vertebral disc nucleus prosthesis into the human body this may be done from the dorsal direction by dissecting away skin, soft tissue and muscle exposing the dorsal aspect of the spinal column.
  • a laminectomy or other surgical procedure may be performed to remove the dorsal bony elements from the column to expose the disc.
  • the disc nucleus prosthesis is then placed in position through a surgical defect created in the posterior surface of the annulus fibrosis.
  • the spinal column may be approached from the dorsal-lateral direction without removing the dorsal bony elements, again introducing the disc nucleus prosthesis through a defect created surgically in the annulus fibrosis.
  • an ventral approach to the spinal column may be used entering the body through the peritoneum or thorax to expose the ventral surface of the spinal column. The disc nucleus prosthesis would then be introduced through a defect created surgically in the anterior surface of the annulus fibrosis.
  • the effected disc level would be distracted using standard surgical instruments to increase the height of the damaged disc to allow insertion of the disc nucleus prosthesis.
  • Any of these surgical approaches may be made using a minimally invasive surgery technique such as arthroscopy, endoscopy or laparoscopy to approach the spinal column.
  • the disc nucleus prosthesis would be introduced through a defect created surgically in the annulus fibrosis through a cannula using a percutaneous approach.
  • the prosthesis may be dehydrated to reduce the volume of the prosthesis prior to insertion.
  • the disc would then either be rehydrated in situ after implantation or be permitted to absorb water from the surrounding tissues during the post-operative period. This technique is particularly suitable for hydrogel prostheses.
  • a complete intervertebral disc prosthesis could be introduced into the human body using any of the techniques described above, with the modification that the entire disc annulus fibrosis and nucleus pulposus or a substantial portion thereof would be removed using standard surgical procedures exposing the vertebral bones, cephalad and caudad to the disc space, and the prosthesis inserted to replace the entire disc.
  • a prosthesis could be anchored using any of the means described previously.
  • Metatin 812ES catalyst Trade Mark for a dioctyltin dilaurate catalyst obtainable from Cima Chemical Industries
  • HPU 45 Hydrophilic polyurethane
  • the cured HPU 45 was then broken into small pieces and dissolved by adding 15 parts by weight of tetrahydrofuran to 85 parts by weight of HPU 45.
  • the resultant liquid was poured into shallow trays and left to evaporate solvent slowly in a fume cupboard over 19 hours.
  • the samples were dried in an oven at 40°C for 4 hours then in a vacuum oven at 40°C for 3 hours.
  • the resultant films were removed from the trays, turned over and the trays replaced in the vacuum oven for a final 5.5 hours.
  • Equally sized discs of diameter 14mm and thickness 1mm were then cut out of the films. From a polyalkylene net obtainable from Smith & Nephew Extruded Films Ltd. of Gilberdyke, UK under the designation of "Net 909 (Grade L40)" further discs of diameter 14mm were cut. The thickness of these discs was 0.15mm and the nets weighed 13.6 g/m 2 .
  • Sample A - Stack consists of two HPU 45 discs, then one net disc, then two HPU 45 discs, then one net disc, then two HPU 45 discs.
  • Sample B (control) - Stack consists of six HPU 45 discs.
  • the discs were laminated together by heating in an oven at 100°C for 10 mins with a 15g weight being placed on the top of each stack.
  • the laminated stacks were allowed to cool to room temperature.
  • Example 2 Synthesis of a poly Hydroxyethylmethacrylate hvdro ⁇ el reinforced with a knitted fabric.
  • a stock solution was prepared by adding azoisobutylnitrile to hydroxyethylmethacrylate (HEMA) at a level of 0.15% w/w. The solution was then de-aerated by bubbling with nitrogen for 15 mins.
  • HEMA hydroxyethylmethacrylate
  • a mould was obtained for producing moulded discs shaped articles of diameter 14mm and depth 9mm.
  • the solution was powered into the mould to a depth of about 2mm and a disc cut out of a knitted "spacer fabric" to have a diameter of 14mm was placed above the HEMA (once it had thickened sufficiently to support the disc).
  • the knitted fabric was obtainable from under the designation of Karl Meyer Textelmaschinen Fabrik of D.63160 Obertshausen, Germany and consists of two planer surfaces interconnected by monofilaments. Each planar surface is knitted to provide a "honeycomb" structure of interconnecting hexagons. It has a thickness of about 5mm.
  • the solution was then poured over the knitted fabric a until the mould was full and the mould was then sealed and put in a water bath (containing a tablespoon of sodium metabisulphite) at 50°C for 3 hours. The temperature was then increased to 80°C for 2 hours and then reduced to 60°C for 17 hours. The mould was finally put in an oven at 100°C for 24 hours to anneal.
  • a water bath containing a tablespoon of sodium metabisulphite
  • sample C After cooling at room temperature for several hours the mould was opened and the moulded article, referred to as sample C, was removed.
  • sample D was also prepared, using a corresponding procedure to that described above except that no knitted fabric was used (ie sample D consisted of poly HEMA only).
  • sample E was prepared, consisting of a sample of the knitted fabric only, cut to the same size as the moulded samples.
  • the testing was carried out on hydrated samples, hydration being performed by immersing samples in 0.9% w/v saline solution at 37°C until no further net intake of water occurred (as determined by weighing samples after various time periods).
  • Fig. 1 Complete stress-strain curves are shown in Fig. 1 for hydrated samples A and B (as indicated by the corresponding letters). In some cases more than one of each type of sample was prepared and therefore more than one stress-strain curve is shown.
  • Fig. 2 the upper parts of the stress-strain curves are shown and it can be seen that at higher loads the traces become more linear. Because of the variability of the initial parts of the curves due to the uneven samples, compression modulus values were obtained •by taking the gradient of the curves at higher loads (between 20-30 kPa) and then were found to give more reproducible results. Moduli calculated from Fig. 2 are summarised in Table 1.

Abstract

Prostheses, e.g. disc nucleus prostheses comprising a resiliently deformable material are reinforced with physically discrete structures to form a composite. The resiliently deformable material may be a hydrophilic polymer such as a hydrogel.

Description

PROSTHETIC DEVICES
The present invention relates to prosthetic devices and in particular to such devices which deform when in use (e.g. when under compressive load).
One type of prosthesis is disclosed in US Patent No. 5047055 and comprises a hydrogel material in a shape which generally conforms to the intervertebral disc nucleus pulposes. When hydrated the hydrogel comprises a certain amount of free water which can leave the prosthesis when the disc is partially dehydrated or under mechanical pressure.
Another type of intervertebral disc nucleus prosthesis is disclosed in US Patent No. 5192326. The prosthesis comprises a multiplicity of hydrogel beads. The beads are covered by an external, semi-permeable membrane, which functions to retain the beads, but which permits fluids to flow in and out of the prosthetic nucleus.
The hydrogel materials employed in these prior devices have a tendency to become weaker and less able to withstand compressive loading as they become more fully hydrated. This may lead to failure of the prosthesis by fragmentation of the prosthesis material.
The present invention seeks to reduce the risk of stress failure of said prostheses to reduce the risk of fragmentation which may lead to adverse reactions in a host.
According to the present invention there is provided a prosthesis comprising a composite of a synthetic resiliently deformable material having at least partially embedded therein a physically discrete reinforcing structure.
In addition to ameliorating disadvantages with prior art devices a further advantage of the prosthesis of the present invention is that it allows a wider range of resiliently deformable materials to be utilised than was hitherto the case. This is because the reinforcing structure can substantially contribute to the physical strength of the device, thereby allowing weaker deformable materials to be used than is the case with non reinforced prostheses.
The prosthesis of the present invention is suitable for replacing body components which are subject to repeated and variable compressive loads and may be shaped so as to correspond to suitable body components. For example it may be used to replace the nucleus pulposus of the intervertebral disc, the intervertebral disc in its entirety, as a replacement for the articular cartilage in joints, in place of orthopaedic bearing surfaces (eg to replace polyethylene bearing surfaces), in total joint replacement implants such as the hip, knee, shoulder, wrist, ankle, fingers and toes, as a spacer to replace segments of bone or the bone in its entirety, as a space filling implant replacing soft tissue for orthopaedic, maxillo-facial, or plastic or reconstructive surgical applications - such as to replace or augment deficiencies in bone, cartilage or soft tissue.
Preferably however the prosthesis is adapted to replace part or all of an intervertebral disc of a mammal, e.g. a human, and is shaped accordingly. Most preferably the prosthesis is adapted to replace an intervertebral disc nucleus and it therefore desirably has a shape generally corresponding to that of a natural disc nucleus. Alternatively it may comprise a plurality of sections which are adapted, when fitted together to approximate the shape of the natural disc nucleus. For example, the nucleus may be in two halves to allow easy manipulation and to facilitate minimally invasive surgical techniques.
The reinforcing structure can be located partially or totally within the resiliently deformable material and is formed of a material which is physically discrete from said resiliently deformable material (although the reinforcing structure may itself be resiliently deformable). It is thus distinguished from systems in which polymers forming the resiliently deformable material are simply cross-linked. The material comprising the reinforcing structure may also be chemically distinct from that of the resilient material.
The reinforcing structure may function by providing a restraining means within the deformable material which reduces the tendency of the latter to shear or otherwise fail when under compressive load.
Desirably, the resiliently deformable material is in solid or semi-solid form. It may be an elastomeric polymer. Preferably it is hydrogel or a hydrophilic polymer.
Suitable hydrogels include PVA hydrogels, such as those disclosed in US-A-5192326.
Other suitable materials for the production of hydrogels or hydrophilic polymers include:
1. Acrylates:- eg acrylic acid, methacrylic acid, 2-hydroxyethyl methacrylate, and copolymers thereof with N-vinyl pyrrolidone, N- vinyl lactams, acylamide, polyurethanes, polyacrylonitrile; copolymers of N-vinyl pyrrolidone and glycidyl acrylate, copolymers of polyethylene, polytetrafluoroethylene or polypropylene with acrylic acid, block copolymers of poly (2-hydroxyethyl methacrylate) with polystyrene, or poly (dimethyl-siloxane), para-hydroxyperfluoro-alkyl styrene, or trifluoroethyl methacrylate;
2. Acrylamides:- eg acrylamide, methacrylamide and copolymers of acrylamides such as poiyacrylamide-agarose gels, siloxy-acryiamides;
3. Silicones:- eg 1 ,3-bis-methacryloxy-propyl-1 ,1 ,3,3-tetrakis (trimethyl-siloxy) disiloxane, tris (trimethyl-siloxy) silyl-propyl methacrylate, siioxane monomers, polysiloxane-polyoxyalkylene macromers, silicone rubbers, hexamethyl disiloxane, triethoxyvinyl silane, hexamethyl disilazane;
4. Collagen:- eg copolymers with poly (2-hydroxyethyl-acrylate) or poly (vinyl alcohol);
5. Vinyl compounds:- eg N-vinyl pyrrolidone, N-vinyl lactams, hydroxyethyl cellulose vinyl and vinylic monomer, polymers of vinyl carbonate or vinyl carbamate, vinyl trifluro acetate;
6. Polyurethanes:- eg polyether, or short chain polyester based polyurethanes.
7. Naturally occurring materials (or chemically modified variants thereof):- eg glucomannan gel, hyaluronic acid, proteins, poiysaccharides or polypeptides combined with a polymer of a hydrophilic acrylic or methacryiic acid derivative, crosslinked carboxyl containing polysaccharides, carboxymethyl cellulose, gelatin, aiginates.
Preferred hydrogels have a water content of at least 30%
(w/w) when fully hydrated at 37°C, more preferably of from 75 to 99%(w/w).
Other elastomeric polymers which may be suitable for use in the present invention include:- silicone and fluorosilicone elastomers, phosphazene elastomers, vinylidine fluoride based fluoroelastomers, natural and artificial rubbers, etc.
The prosthesis of the invention aptly has a compressive strength of at least 1 MNrrr2 at 37°C and at atmospheric pressure.
Suitable reinforcing structures include:- nets; foams; knitted, braided, crocheted, woven, or non-woven fabrics; arrays of spaced reinforcing elements; particulate filler materials; loose fibres.
The term "net" includes perforate films as well as fibrous networks. Suitable nets include those formed of nylon™, dacron™, carbon fibre etc.
The foams may be open cell foams, closed cell foams, skeletal foams, non-skeletal foams, etc. Foams which are already used in wound-dressings for example those polyurethane foams employed in wound dressings such as ALLEVYN™ foam, which is sold by Smith & Nephew Medical Ltd, Hull, UK may be particularly suitable. The fabrics used for reinforcing structures are aptly arranged as composite structures having desirably first and second spaced apart sheets whose opposed surfaces are maintained in a spaced apart relationship by a plurality of supporting members. The first and second spaced apart surfaces may be generally parallel to one another (when the fabric is not compressed). They may be generally planar or may present corrugated surfaces. Such fabrics are often formed by warp knitting using Raschel warp knitting machinery (as described eg in USPN 4601940 and EP-A-0529671). Certain type of fabrics of this are sometimes referred to as "spacer fabric" and have been used in seating in the automotive industry. Such fabrics can be obtained from Messrs. Nippon Mayer Co. Ltd. of J-910 Fukui City, Japan; Mϋller Textile GmbH of D-51674 Wiehl- Drabenderhδhe, Germany; or Karl Mayer Textilmaschienen fabrik of D-63160 Obertshaϋsen, Germany.
The surfaces of these composite structures may be maintained in the spaced apart relationship by, for example, columns of elastomeric material or by a plurality of fibrous members arranged, for example to form a web. Such webs may be formed from non-woven fabrics.
The particulate filler material may employed is the reinforcing structure may be quartz, silica, gypsum, titanium dioxide, glass based fillers, clay-based fillers, or calcium carbonate. Filler materials are described in detail in the "Handbook of Fillers for Plastics" by Katz and Mikwski [1987], published by Van Nostrand Reinhold.
In certain cases the resiliently deformable material may be contained within an outer cover, which is desirably flexible. Aptly the outer cover is suitably non-permeable to body fluids.
Alternatively, the outer cover may be provided to simply serve to assist in maintaining integrity or strength of the prosthesis. The outer cover may therefore be permeable to body fluids but prevent the resiliently deformable material and the reinforcing structure from passing through it. Aptly such outer covers will be in the form of a membrane or mesh. Various outer covers are disclosed in US-A- 5192326.
In the case of a replacement intervertebral disc, it may be desired to provide a prosthesis with additional means to externally reinforce and/or anchor the device.
This may take the form of a collar surrounding the prosthesis to constrain its lateral deflection. This collar may be of metal, polymeric, ceramic or composite construction and would surround the prosthesis circumferentially. This collar may be made of implantable metals such as stainless steel, cobalt chrome alloy, titanium alloy or ceramic materials such as alumina or zirconia, or composite materials such as carbon fibre reinforced PEEK, or polymers such as polyethylene. Alternatively the prosthesis may be bonded to plates of metal, ceramic, polymer or composite construction which are interspersed between the prosthesis and the bone of the vertebral bodies in cephalad and caudad directions to facilitate anchorage to the bone.
Once the prosthesis of the present invention has been formed it is necessary to introduce it into a host. This can be done by any appropriate surgical technique, but minimally invasive techniques are preferred where possible. In order to introduce a prosthesis consisting of an inter¬ vertebral disc nucleus prosthesis into the human body this may be done from the dorsal direction by dissecting away skin, soft tissue and muscle exposing the dorsal aspect of the spinal column. A laminectomy or other surgical procedure may be performed to remove the dorsal bony elements from the column to expose the disc. The disc nucleus prosthesis is then placed in position through a surgical defect created in the posterior surface of the annulus fibrosis.
Alternatively the spinal column may be approached from the dorsal-lateral direction without removing the dorsal bony elements, again introducing the disc nucleus prosthesis through a defect created surgically in the annulus fibrosis. As a further alternative, an ventral approach to the spinal column may be used entering the body through the peritoneum or thorax to expose the ventral surface of the spinal column. The disc nucleus prosthesis would then be introduced through a defect created surgically in the anterior surface of the annulus fibrosis.
In each of these cases it is anticipated that the effected disc level would be distracted using standard surgical instruments to increase the height of the damaged disc to allow insertion of the disc nucleus prosthesis. Any of these surgical approaches may be made using a minimally invasive surgery technique such as arthroscopy, endoscopy or laparoscopy to approach the spinal column. In this case the disc nucleus prosthesis would be introduced through a defect created surgically in the annulus fibrosis through a cannula using a percutaneous approach. The prosthesis may be dehydrated to reduce the volume of the prosthesis prior to insertion. The disc would then either be rehydrated in situ after implantation or be permitted to absorb water from the surrounding tissues during the post-operative period. This technique is particularly suitable for hydrogel prostheses.
A complete intervertebral disc prosthesis could be introduced into the human body using any of the techniques described above, with the modification that the entire disc annulus fibrosis and nucleus pulposus or a substantial portion thereof would be removed using standard surgical procedures exposing the vertebral bones, cephalad and caudad to the disc space, and the prosthesis inserted to replace the entire disc. A prosthesis could be anchored using any of the means described previously.
The following examples, which are not to be construed as limiting, illustrate ways in which articles can be formed from resiliently deformable material and reinforced with reinforcing structures. For convenience the examples illustrate the production of generally cylindrical articles. In practice however these techniques would be used to produce a prosthesis, or a component thereof, shaped as desired.
Example 1 - Synthesis of polyurethane structures reinforced with nets
The following reagents were stirred together at 60°C until a homogenous composition was obtained:-
86.3g of ethanediol
565.7g of freshly dried polyethylene glycol PEG 1500 447.9g of Desmodur W (Trade Mark for a 4,4 -
Dicyclohexyimethane di-isocyanate (obtainable from
Bayer UK Limited).
2.2g of Metatin 812ES catalyst (Trade Mark for a dioctyltin dilaurate catalyst obtainable from Cima Chemical Industries) was then added with vigorous stirring until exotherm commenced, after which the mixture was poured onto a polypropylene tray then covered with PTFE sheet and placed in an oven to cure at 90°C for 2 hours to produce a hydrophilic polyurethane, which is referred to herein as "HPU 45"
The cured HPU 45 was then broken into small pieces and dissolved by adding 15 parts by weight of tetrahydrofuran to 85 parts by weight of HPU 45.
The resultant liquid was poured into shallow trays and left to evaporate solvent slowly in a fume cupboard over 19 hours. The samples were dried in an oven at 40°C for 4 hours then in a vacuum oven at 40°C for 3 hours. The resultant films were removed from the trays, turned over and the trays replaced in the vacuum oven for a final 5.5 hours.
Equally sized discs of diameter 14mm and thickness 1mm were then cut out of the films. From a polyalkylene net obtainable from Smith & Nephew Extruded Films Ltd. of Gilberdyke, UK under the designation of "Net 909 (Grade L40)" further discs of diameter 14mm were cut. The thickness of these discs was 0.15mm and the nets weighed 13.6 g/m2.
Different arrangements were produced as follows:- Sample A - Stack consists of two HPU 45 discs, then one net disc, then two HPU 45 discs, then one net disc, then two HPU 45 discs.
Sample B (control) - Stack consists of six HPU 45 discs.
Once the stacks were formed the discs were laminated together by heating in an oven at 100°C for 10 mins with a 15g weight being placed on the top of each stack.
After removal from the oven, the laminated stacks were allowed to cool to room temperature.
Example 2 - Synthesis of a poly Hydroxyethylmethacrylate hvdroαel reinforced with a knitted fabric.
A stock solution was prepared by adding azoisobutylnitrile to hydroxyethylmethacrylate (HEMA) at a level of 0.15% w/w. The solution was then de-aerated by bubbling with nitrogen for 15 mins.
A mould was obtained for producing moulded discs shaped articles of diameter 14mm and depth 9mm. The solution was powered into the mould to a depth of about 2mm and a disc cut out of a knitted "spacer fabric" to have a diameter of 14mm was placed above the HEMA (once it had thickened sufficiently to support the disc). The knitted fabric was obtainable from under the designation of Karl Meyer Textelmaschinen Fabrik of D.63160 Obertshausen, Germany and consists of two planer surfaces interconnected by monofilaments. Each planar surface is knitted to provide a "honeycomb" structure of interconnecting hexagons. It has a thickness of about 5mm. The solution was then poured over the knitted fabric a until the mould was full and the mould was then sealed and put in a water bath (containing a tablespoon of sodium metabisulphite) at 50°C for 3 hours. The temperature was then increased to 80°C for 2 hours and then reduced to 60°C for 17 hours. The mould was finally put in an oven at 100°C for 24 hours to anneal.
After cooling at room temperature for several hours the mould was opened and the moulded article, referred to as sample C, was removed.
A control sample, sample D, was also prepared, using a corresponding procedure to that described above except that no knitted fabric was used (ie sample D consisted of poly HEMA only).
A further control sample, sample E, was prepared, consisting of a sample of the knitted fabric only, cut to the same size as the moulded samples.
Physical Testing of Samples
Static compression testing was carried out on samples prepared according to Examples 1 and 2 using a Rheometrics Solid Analyser RSA II, available from Rheometrics (UK), Englefield Green, Surrey, UK. In the tests strain was increased in steps of 0.2% up to approximately 30%.
The testing was carried out on hydrated samples, hydration being performed by immersing samples in 0.9% w/v saline solution at 37°C until no further net intake of water occurred (as determined by weighing samples after various time periods).
Complete stress-strain curves are shown in Fig. 1 for hydrated samples A and B (as indicated by the corresponding letters). In some cases more than one of each type of sample was prepared and therefore more than one stress-strain curve is shown.
The results are variable and most samples showed an initially low gradient which increases with increasing load. This is probabiy due to the fact that some samples were uneven and the top and bottom surfaces were not perfectly parallel.
In Fig. 2 the upper parts of the stress-strain curves are shown and it can be seen that at higher loads the traces become more linear. Because of the variability of the initial parts of the curves due to the uneven samples, compression modulus values were obtained •by taking the gradient of the curves at higher loads (between 20-30 kPa) and then were found to give more reproducible results. Moduli calculated from Fig. 2 are summarised in Table 1.
Table 1
Hydrated Sample Modulus/kPa Mean Modulus/kPa
B 236 234
233
A 280
280 284
293
The results show an average increase of over 20% in stiffness for the samples with 2 layers of net compared to samples with
HPU45 alone.
The same testing procedure described above was performed upon samples C, D and E and the results are shown in Figs. 3 and 4. Gradients were calculated at high loads (20-30 kPa) and the results are illustrated in Table 2 below.
Table 2
Sample Modulus/kPa Mean Modulus/kPa
D 644 643
625
660
C 923 863
855
E 424 424 The results show an average increase in stiffness of over 30% for the poly HEMA samples reinforced with the knitted fabrics relative to poly HEMA alone.

Claims

1. A prosthesis comprising a composite of a synthetic resiliently deformable matrix material having at least partially embedded therein a physically discrete reinforcing structure.
2. A prosthesis as claimed in claim 1 having a compression strength of at least 1MNm"2 (at 37°C and atmospheric pressure).
3. A prosthesis as claimed in claim 1 or claim 2 wherein the resiliently deformable material is a hydrophilic polymer.
4. A prosthesis as claimed in claim 3 where the hydrophilic polymer is a hydrogel.
5. A prosthesis as claimed in claim 4 wherein the hydrogel has a water content of at least 30% (w/w) when fully hydrated at 37°C.
6. A prosthesis as claimed in any one of the preceding claims wherein the reinforcing structure comprises one or more materials chemically distinct from that of the resiliently deformable material.
7. A prosthesis as claimed in any one of the preceding claims wherein the reinforcing structure comprises a net, a foam, knitted, woven or non-woven fabrics.
8. A prosthesis as claimed in claim 7 wherein the reinforcing structure comprise at least one pair of sheets maintained in spaced apart relationship by a plurality of supporting members.
9. A prosthesis as claimed in claim 8 wherein the supporting members are physically defined by fibrous web.
10. A prosthesis as claimed in any one of the preceding claims wherein the resiliently deformable material is at least partially enveloped by and contained within a cover.
11. A prosthesis as claimed in claim 10 wherein the cover is non- permeable to body fluids.
12. A prosthesis as claimed in claim 10 or claim 11 wherein the cover forms part of the reinforcing structure.
13. A prosthesis as claimed in claim 10 or claim 11 wherein said sheets as defined in claim 8 comprise the cover.
14. A prosthesis as claimed in any one of the preceding claims further provided with additional wholly external support means.
15. A disc nucleus prosthesis as defined in any one of the preceding claims.
PCT/GB1995/001550 1994-07-08 1995-07-03 Prosthetic devices WO1996001598A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU28020/95A AU2802095A (en) 1994-07-08 1995-07-03 Prosthetic devices

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9413855.9 1994-07-08
GB9413855A GB9413855D0 (en) 1994-07-08 1994-07-08 Prosthetic devices

Publications (1)

Publication Number Publication Date
WO1996001598A1 true WO1996001598A1 (en) 1996-01-25

Family

ID=10758068

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1995/001550 WO1996001598A1 (en) 1994-07-08 1995-07-03 Prosthetic devices

Country Status (3)

Country Link
AU (1) AU2802095A (en)
GB (1) GB9413855D0 (en)
WO (1) WO1996001598A1 (en)

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787018A1 (en) * 1998-12-11 2000-06-16 Dimso Sa INTERVERTEBRAL DISC PROSTHESIS WITH LIQUID ENCLOSURE
WO2002038197A2 (en) * 2000-11-09 2002-05-16 The Polymer Technology Group, Inc. Devices that change size/shape via osmotic pressure
WO2002085262A1 (en) * 2001-04-24 2002-10-31 Galley Geoffrey H Surgical restoration of an intervertebral disc
US6620196B1 (en) 2000-08-30 2003-09-16 Sdgi Holdings, Inc. Intervertebral disc nucleus implants and methods
US6733531B1 (en) 2000-10-20 2004-05-11 Sdgi Holdings, Inc. Anchoring devices and implants for intervertebral disc augmentation
US6733532B1 (en) 1998-12-11 2004-05-11 Stryker Spine Intervertebral disc prosthesis with improved mechanical behavior
US6974479B2 (en) 2002-12-10 2005-12-13 Sdgi Holdings, Inc. System and method for blocking and/or retaining a prosthetic spinal implant
US7066960B1 (en) * 2002-06-28 2006-06-27 Dickman Curtis A Intervertebral disk replacement
US7204897B2 (en) * 1999-09-30 2007-04-17 Replication Medical, Inc. Hydrogel-based prosthetic device for replacing at least a part of the nucleus of a spinal disc
US7204851B2 (en) 2000-08-30 2007-04-17 Sdgi Holdings, Inc. Method and apparatus for delivering an intervertebral disc implant
US7297146B2 (en) 2004-01-30 2007-11-20 Warsaw Orthopedic, Inc. Orthopedic distraction implants and techniques
US7503936B2 (en) 2000-08-30 2009-03-17 Warsaw Orthopedic, Inc. Methods for forming and retaining intervertebral disc implants
US8012187B2 (en) 2002-08-14 2011-09-06 Warsaw Orthopedic, Inc. Techniques for spinal surgery and attaching constructs to vertebral elements
US8066750B2 (en) 2006-10-06 2011-11-29 Warsaw Orthopedic, Inc Port structures for non-rigid bone plates
US8262731B2 (en) 2002-05-23 2012-09-11 Pioneer Surgical Technology, Inc. Artificial disc device
US8663225B2 (en) 2004-11-12 2014-03-04 Medtronic, Inc. Hydrogel bone void filler
US9039741B2 (en) 2005-12-28 2015-05-26 Intrinsic Therapeutics, Inc. Bone anchor systems
US9226832B2 (en) 2007-09-07 2016-01-05 Intrinsic Therapeutics, Inc. Interbody fusion material retention methods
US9233011B2 (en) 2006-09-15 2016-01-12 Pioneer Surgical Technology, Inc. Systems and apparatuses for inserting an implant in intervertebral space
US9241807B2 (en) 2011-12-23 2016-01-26 Pioneer Surgical Technology, Inc. Systems and methods for inserting a spinal device
US9333087B2 (en) 1999-08-18 2016-05-10 Intrinsic Therapeutics, Inc. Herniated disc repair
US9351852B2 (en) 2002-05-23 2016-05-31 Pioneer Surgical Technology, Inc. Artificial disc device
US9445916B2 (en) 2003-10-22 2016-09-20 Pioneer Surgical Technology, Inc. Joint arthroplasty devices having articulating members
US9706947B2 (en) 1999-08-18 2017-07-18 Intrinsic Therapeutics, Inc. Method of performing an anchor implantation procedure within a disc
USD907771S1 (en) 2017-10-09 2021-01-12 Pioneer Surgical Technology, Inc. Intervertebral implant
US11147682B2 (en) 2017-09-08 2021-10-19 Pioneer Surgical Technology, Inc. Intervertebral implants, instruments, and methods

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867728A (en) * 1971-12-30 1975-02-25 Cutter Lab Prosthesis for spinal repair
EP0346129A1 (en) * 1988-06-10 1989-12-13 University Of Medicine And Dentistry Of New Jersey Functional and biocompatible intervertebral disc spacer
EP0372811A1 (en) * 1988-12-02 1990-06-13 Stryker Corporation Implant
US5047055A (en) * 1990-12-21 1991-09-10 Pfizer Hospital Products Group, Inc. Hydrogel intervertebral disc nucleus

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867728A (en) * 1971-12-30 1975-02-25 Cutter Lab Prosthesis for spinal repair
EP0346129A1 (en) * 1988-06-10 1989-12-13 University Of Medicine And Dentistry Of New Jersey Functional and biocompatible intervertebral disc spacer
EP0372811A1 (en) * 1988-12-02 1990-06-13 Stryker Corporation Implant
US5047055A (en) * 1990-12-21 1991-09-10 Pfizer Hospital Products Group, Inc. Hydrogel intervertebral disc nucleus

Cited By (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733532B1 (en) 1998-12-11 2004-05-11 Stryker Spine Intervertebral disc prosthesis with improved mechanical behavior
WO2000035386A1 (en) * 1998-12-11 2000-06-22 Dimso (Distribution Medicale Du Sud-Ouest) Intervertebral disc prosthesis with liquid chamber
US6395032B1 (en) 1998-12-11 2002-05-28 Dimso (Distribution Medicale Du Sud-Ouest) Intervertebral disc prosthesis with liquid chamber
AU765060B2 (en) * 1998-12-11 2003-09-04 Stryker Spine Intervertebral disc prosthesis with liquid chamber
FR2787018A1 (en) * 1998-12-11 2000-06-16 Dimso Sa INTERVERTEBRAL DISC PROSTHESIS WITH LIQUID ENCLOSURE
US9706947B2 (en) 1999-08-18 2017-07-18 Intrinsic Therapeutics, Inc. Method of performing an anchor implantation procedure within a disc
US9333087B2 (en) 1999-08-18 2016-05-10 Intrinsic Therapeutics, Inc. Herniated disc repair
US7204897B2 (en) * 1999-09-30 2007-04-17 Replication Medical, Inc. Hydrogel-based prosthetic device for replacing at least a part of the nucleus of a spinal disc
US6893466B2 (en) 2000-08-30 2005-05-17 Sdgi Holdings, Inc. Intervertebral disc nucleus implants and methods
US7503936B2 (en) 2000-08-30 2009-03-17 Warsaw Orthopedic, Inc. Methods for forming and retaining intervertebral disc implants
US7204851B2 (en) 2000-08-30 2007-04-17 Sdgi Holdings, Inc. Method and apparatus for delivering an intervertebral disc implant
US6620196B1 (en) 2000-08-30 2003-09-16 Sdgi Holdings, Inc. Intervertebral disc nucleus implants and methods
US6733531B1 (en) 2000-10-20 2004-05-11 Sdgi Holdings, Inc. Anchoring devices and implants for intervertebral disc augmentation
US6692528B2 (en) 2000-11-09 2004-02-17 The Polymer Technology Group Incorporated Devices that change size/shape via osmotic pressure
WO2002038197A2 (en) * 2000-11-09 2002-05-16 The Polymer Technology Group, Inc. Devices that change size/shape via osmotic pressure
US7368056B2 (en) 2000-11-09 2008-05-06 The Polymer Technology Group, Incorporated Production of potable liquids
WO2002038197A3 (en) * 2000-11-09 2002-10-10 Polymer Technology Group Inc Devices that change size/shape via osmotic pressure
WO2002085262A1 (en) * 2001-04-24 2002-10-31 Galley Geoffrey H Surgical restoration of an intervertebral disc
US9351852B2 (en) 2002-05-23 2016-05-31 Pioneer Surgical Technology, Inc. Artificial disc device
US8262731B2 (en) 2002-05-23 2012-09-11 Pioneer Surgical Technology, Inc. Artificial disc device
US7066960B1 (en) * 2002-06-28 2006-06-27 Dickman Curtis A Intervertebral disk replacement
US8012187B2 (en) 2002-08-14 2011-09-06 Warsaw Orthopedic, Inc. Techniques for spinal surgery and attaching constructs to vertebral elements
US6974479B2 (en) 2002-12-10 2005-12-13 Sdgi Holdings, Inc. System and method for blocking and/or retaining a prosthetic spinal implant
US9445916B2 (en) 2003-10-22 2016-09-20 Pioneer Surgical Technology, Inc. Joint arthroplasty devices having articulating members
US7297146B2 (en) 2004-01-30 2007-11-20 Warsaw Orthopedic, Inc. Orthopedic distraction implants and techniques
US8142476B2 (en) 2004-01-30 2012-03-27 Warsaw Orthopedic, Inc. Orthopedic distraction implants and techniques
US8663225B2 (en) 2004-11-12 2014-03-04 Medtronic, Inc. Hydrogel bone void filler
US9610106B2 (en) 2005-12-28 2017-04-04 Intrinsic Therapeutics, Inc. Bone anchor systems
US9039741B2 (en) 2005-12-28 2015-05-26 Intrinsic Therapeutics, Inc. Bone anchor systems
US11185354B2 (en) 2005-12-28 2021-11-30 Intrinsic Therapeutics, Inc. Bone anchor delivery systems and methods
US10470804B2 (en) 2005-12-28 2019-11-12 Intrinsic Therapeutics, Inc. Bone anchor delivery systems and methods
US9233011B2 (en) 2006-09-15 2016-01-12 Pioneer Surgical Technology, Inc. Systems and apparatuses for inserting an implant in intervertebral space
US9693872B2 (en) 2006-09-15 2017-07-04 Pioneer Surgical Technology, Inc. Intervertebral disc implant
US10080667B2 (en) 2006-09-15 2018-09-25 Pioneer Surgical Technology, Inc. Intervertebral disc implant
US8066750B2 (en) 2006-10-06 2011-11-29 Warsaw Orthopedic, Inc Port structures for non-rigid bone plates
US9226832B2 (en) 2007-09-07 2016-01-05 Intrinsic Therapeutics, Inc. Interbody fusion material retention methods
US10716685B2 (en) 2007-09-07 2020-07-21 Intrinsic Therapeutics, Inc. Bone anchor delivery systems
US10076424B2 (en) 2007-09-07 2018-09-18 Intrinsic Therapeutics, Inc. Impaction systems
US9241807B2 (en) 2011-12-23 2016-01-26 Pioneer Surgical Technology, Inc. Systems and methods for inserting a spinal device
US10980575B2 (en) 2011-12-23 2021-04-20 Pioneer Surgical Technology, Inc. Instrument for inserting a spinal device
US10159514B2 (en) 2011-12-23 2018-12-25 Pioneer Surgical Technology, Inc. Method of implanting a bone plate
US11696786B2 (en) 2011-12-23 2023-07-11 Pioneer Surgical Technology, Inc. Instrument for inserting a spinal device
US11147682B2 (en) 2017-09-08 2021-10-19 Pioneer Surgical Technology, Inc. Intervertebral implants, instruments, and methods
USD907771S1 (en) 2017-10-09 2021-01-12 Pioneer Surgical Technology, Inc. Intervertebral implant
USD968613S1 (en) 2017-10-09 2022-11-01 Pioneer Surgical Technology, Inc. Intervertebral implant

Also Published As

Publication number Publication date
AU2802095A (en) 1996-02-09
GB9413855D0 (en) 1994-08-24

Similar Documents

Publication Publication Date Title
WO1996001598A1 (en) Prosthetic devices
USRE42837E1 (en) Spinal nucleus implant
US5047055A (en) Hydrogel intervertebral disc nucleus
JP2735517B2 (en) Hydrogel intervertebral disc nucleus
EP0563332B1 (en) Hydrogel intervertebral disc nucleus
US7503936B2 (en) Methods for forming and retaining intervertebral disc implants
JP3909049B2 (en) Radiovisible hydrogel intervertebral disc nucleus
US6187048B1 (en) Intervertebral disc implant
US6620196B1 (en) Intervertebral disc nucleus implants and methods
US20020183845A1 (en) Multi-perforated non-planar device for anchoring cartilage implants and high-gradient interfaces
KR100980170B1 (en) Hydrogel-Based Prosthetic Device for Replacing at Least a Part of the Nucleus of a Spinal Disc
JP2007504899A (en) Flexible spine
AU2004322968A1 (en) Inflatable nuclear prosthesis
EP1993481A2 (en) Methods of producing pva hydrogel implants and related devices
WO2006096889A2 (en) Materials, devices, and methods for in-situ formation of composite intervertebral implants
AU2003205191B2 (en) Hydrogel-based prosthetic device for replacing at least a part of the nucleus of a spinal disc
AU2007203293A1 (en) Hydrogel-based prosthetic device for replacing at least a part of the nucleus of a spinal disc

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NO NZ PL PT RO RU SD SE SI SK TJ TT UA US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase